论文部分内容阅读
用~(111)铟标记白细胞(IWC)做全身扫描来评价接受肾器官移植的病人,这是一个很有前途的研究。根据初步研究证明,这种放射性核素的检查,可以做为肾移植排斥的早期指标。方法和结果:静脉注射约500微居里的IWC,注射后4和24小时做常规全身扫描。对接受肾移植的9名病人共做了11次全身扫描。其扫描结果与病人的临床状态,血清肌酐,血尿素氮,OIH肾图和肾活组织检查之间有密切关系。
It is a promising study to evaluate the use of ~ (111) indium labeled leukocytes (IWC) for whole body scans in patients undergoing kidney transplantation. Preliminary studies have shown that this radionuclide examination can be used as an early indicator of renal transplant rejection. Methods and Results: Intravenous injection of approximately 500 microcarrier IWC was performed at 4 and 24 hours post-injection for a conventional whole-body scan. Nine patients undergoing renal transplantation performed a total of 11 whole-body scans. The results of this scan are closely related to the patient’s clinical status, serum creatinine, blood urea nitrogen, OIH renal mapping, and renal biopsy.